CYTOSORBENTS CORPORATION Shareholders' Equity
CYTOSORBENTS CORPORATION (CTSO) had Shareholders' Equity of -$751.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$751.00K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.19M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.90M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.02M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$751.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $2.19M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $5.90M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.02M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $11.59M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $14.54M 10-Q · filed 2026-08-06 | $14.54M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $11.11M 10-Q · filed 2026-08-06 | $11.11M 10-K · filed 2025-03-31 |
| 2024-09-30 | $13.38M 10-Q · filed 2025-11-13 | $13.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $17.43M 10-Q · filed 2025-11-13 | $16.74M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $19.63M 10-Q · filed 2025-08-07 | $18.93M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $23.48M 10-K · filed 2026-03-30 | $23.28M 10-K · filed 2024-03-15 |
| 2023-09-30 | $18.81M 10-K · filed 2025-03-31 | $18.51M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $24.46M 10-K · filed 2025-03-31 | $24.09M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $29.94M 10-K · filed 2025-03-31 | $28.96M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $35.37M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $39.14M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $47.56M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $55.43M 10-Q · filed 2023-08-01 | |
| 2021-12-31 | $62.58M 10-K · filed 2024-03-15 | |
| 2021-09-30 | $70.61M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $74.38M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $77.26M 10-Q · filed 2022-08-02 | |
| 2020-12-31 | $79.22M 10-K · filed 2024-03-15 | |
| 2020-09-30 | $80.23M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $24.32M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $21.31M 10-Q · filed 2021-08-03 | |
| 2019-12-31 | $3.42M 10-K · filed 2023-03-09 | |
| 2019-09-30 | $6.73M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $11.54M 10-Q · filed 2020-11-04 | $11.54M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $15.01M 10-Q · filed 2020-08-04 | |
| 2018-12-31 | $16.93M 10-K · filed 2022-03-10 | |
| 2018-09-30 | $20.07M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $21.56M 10-Q · filed 2019-11-05 | $21.56M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $14.45M 10-Q · filed 2019-08-06 | $14.45M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $10.26M 10-K · filed 2021-03-09 | |
| 2017-09-30 | $9.47M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $7.92M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | -$1.57M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.34M 10-K · filed 2020-03-05 | -$474.09K 10-K · filed 2017-03-03 |
| 2016-09-30 | $1.38M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $3.90M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.26M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $9.85M 10-K · filed 2019-03-07 | $8.21M 10-K · filed 2016-03-09 |
| 2015-09-30 | $9.36M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $11.57M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $9.67M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $6.94M 10-K · filed 2018-03-08 | $3.96M 10-K · filed 2015-03-31 |
| 2014-09-30 | -$10.80M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$9.23M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$7.26M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$14.27M 10-K · filed 2017-03-03 | |
| 2013-09-30 | -$13.61M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$13.19M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$11.94M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$11.63M 10-K · filed 2015-03-31 | |
| 2012-09-30 | $1.19M 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $591.98K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $535.28K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$10.09M 10-K · filed 2014-03-31 | $318.34K 10-K · filed 2012-03-30 |
| 2011-09-30 | $1.12M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.92M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$8.07M 10-K · filed 2014-03-31 | -$484.58K 10-Q · filed 2011-08-15 |
| 2009-12-31 | -$5.74M 10-K · filed 2014-03-31 | $1.27M 10-K · filed 2012-03-30 |
| 2008-12-31 | -$3.35M 10-K · filed 2014-03-31 | $2.36M 10-K · filed 2012-03-30 |
| 2007-12-31 | -$104.30K 10-K · filed 2014-03-31 | |
| 2006-12-31 | $2.36M 10-K · filed 2014-03-31 | |
| 2005-12-31 | -$9.76M 10-K · filed 2014-03-31 | |
| 2004-12-31 | -$6.97M 10-K · filed 2014-03-31 | |
| 2003-12-31 | -$3.91M 10-K · filed 2014-03-31 | |
| 2002-12-31 | -$4.37M 10-K · filed 2014-03-31 | |
| 2001-12-31 | $2.33M 10-K · filed 2014-03-31 | |
| 2000-12-31 | $5.34M 10-K · filed 2014-03-31 | |
| 1999-12-31 | $100.55K 10-K · filed 2014-03-31 | |
| 1998-12-31 | $1.58M 10-K · filed 2014-03-31 | |
| 1997-12-31 | $877.48K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |